Business

"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Indicative Announcement on Acceptance of Application for Drug Marketing Authorization and Inclusion into the Priority Review Program

"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Indicative Announcement on Acceptance of Application for Drug Marketing Authorization and Inclusion into the Priority Review Program

articleJiangsu Hengrui Pharmaceuticals Co., Ltd. Class AJuly 2, 20264/news/jiangsu-hengrui-pharmaceuticals-co-ltdindicative-announcement-on-acceptance-of-application-for-drug-marketing-authorization-and-inclusion-into-the-priority-review-program
"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Indicative Announcement on Acceptance of Application for Drug Marketing Authorization and Inclusion into the Priority Review Program

About this update from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

Indicative Announcement on Acceptance of Application for Drug Marketing Authorization and Inclusion into the Priority Review ProgramThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:View Attachment

View stock analysis, news, and events for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A